THE BURRILL REPORT: AN INTERVIEW WITH ANTHONY GIOVINAZZO, PRESIDENT AND CEO, CYNAPSUS THERAPEUTICS

April 5, 2011

Cynapsus Therapeutics is a small Canadian specialty pharma trying to reinvent itself. Under Anthony Giovinazzo, who took the helm at the end of 2009, the company has a new name and new focus. It’s hoping that its reformulation of an existing treatment for Parkinson’s disease can put it on a fast path to revenue with limited investment. MORE>>